Mechanisms in decorin regulation of vascular endothelial growth factor-induced human trophoblast migration and acquisition of endothelial phenotype

Biology of Reproduction

Volumn 87, Issue 3, 2012, Pages

  Lala, Neena ^a   Girish, Gannareddy V ^a   Cloutier Bosworth, Alia ^a   Lala, Peeyush K ^a  

^a WESTERN UNIVERSITY   (Canada)

Author keywords

catenin; Decorin; Endovascular differentiation; Extravillous trophoblast; Migration; Mitogen activated protein kinases; Placenta; Vascular endothelial growth factor; VE cadherin

Indexed keywords

BETA CATENIN; DECORIN; MATRIGEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; TYROSINE KINASE RECEPTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRAVILLOUS TROPHOBLAST; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; RECEPTOR BINDING; TROPHOBLAST; UPREGULATION; VASCULAR ENDOTHELIUM;

CELL DIFFERENTIATION; CELL MOVEMENT; CELLS, CULTURED; DECORIN; DRUG ANTAGONISM; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PHENOTYPE; PREGNANCY; SIGNAL TRANSDUCTION; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84869416110     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.111.097881     Document Type: Article

References (64)

1. Lala PK, Hamilton GS. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996; 17:545-555.
2. Huppertz B. The anatomy of the normal placenta. J Clin Pathol 2008; 61:1296-1302.
3. Espinoza J, Romero R, Mee KY, Kusanovic JP, Hassan S, Erez O, Gotsch F, Than NG, Papp Z, Jai KC. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006; 34:447-458.
4. Pijnenborg R, Vercruysse L, Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27:939-958.
5. Burton GJ, Woods AW, Jauniaux E, Kingdom JC. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta 2009; 30:473-482.
6. Knofler M. Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol 2010; 54:269-280.
7. Lunghi L, Ferretti ME, Medici S, Biondi C, Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol 2007; 5:6.
8. Chakraborty C, Gleeson LM, McKinnon T, Lala PK. Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol 2002;80:116-124.
9. Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta 2003; 24:575-587.
10. Bauer S, Pollheimer J, Hartmann J, Husslein P, Aplin JD, Knofler M.Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab 2004; 89:812-822.
11. Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol 1991; 148:228-234.
12. Graham CH, Lysiak JJ, McCrae KR, Lala PK. Localization of transforming growth factor-beta at the human fetal-maternal interface:role in trophoblast growth and differentiation. Biol Reprod 1992; 46:561-572.
13. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N, Lala PK. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 1993; 206:204-211.
14. Irving JA, Lala PK. Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1.Exp Cell Res 1995; 217:419-427.
15. Lysiak JJ, Hunt J, Pringle GA, Lala PK. Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995; 16:221-231.
16. Xu G, Guimond MJ, Chakraborty C, Lala PK. Control of proliferation,migration, and invasiveness of human extravillous trophoblast by decorin,a decidual product. Biol Reprod 2002; 67:681-689.
17. Iacob D, Cai J, Tsonis M, Babwah A, Chakraborty C, Bhattacharjee RN,Lala PK. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors. Endocrinology 2008; 149:6187-6197.
18. Khan GA, Girish GV, Lala N, Di Guglielmo GM, Lala PK. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast.Mol Endocrinol 2011; 25:1431-1443.
19. Davies CL, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y.Decorin inhibits endothelial migration and tube-like structure formation:role of thrombospondin-1. Microvasc Res 2001; 62:26-42.
20. Kinsella MG, Fischer JW, Mason DP, Wight TN. Retrovirally mediated expression of decorin by macrovascular endothelial cells. Effects on cellular migration and fibronectin fibrillogenesis in vitro. J Biol Chem 2000; 275:13924-13932
21. Winnemoller M, Schon P, Vischer P, Kresse H. Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol 1992; 59:47-55.
22. Fan H, Sulochana KN, Chong YS, Ge R. Decorin derived antiangiogenic peptide LRR5 inhibits endothelial cell migration by interfering with VEGF-stimulated NO release. Int J Biochem Cell Biol 2008; 40:2120-2128.
23. Sulochana KN, Fan H, Jois S, Subramanian V, Sun F, Kini RM, Ge R.Peptides derived from human decorin leucine-rich repeat 5 inhibit angiogenesis. J Biol Chem 2005; 280:27935-27948.
24. Holmes K, Roberts OL, Thomas AM, Cross MJ. Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cell Signal 2007; 19:2003-2012.
25. Kliche S, Waltenberger J. VEGF receptor signaling and endothelial function. IUBMB Life 2001; 52:61-66.
26. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH.Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269:26988-26995.
27. Abedi H, Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 1997; 272:15442-15451.
28. Feliers D, Chen X, Akis N, Choudhury GG, Madaio M, Kasinath BS.VEGF regulation of endothelial nitric oxide synthase in glomerular endothelial cells. Kidney Int 2005; 68:1648-1659.
29. Henriksen K, Karsdal M, Delaisse JM, Engsig MT. RANKL and vascular endothelial growth factor (VEGF) induce osteoclast chemotaxis through an ERK1/2-dependent mechanism. J Biol Chem 2003; 278:48745-48753.
30. Rousseau S, Houle F, Landry J, Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997; 15:2169-2177.
31. Dejana E, Spagnuolo R, Bazzoni G. Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration. Thromb Haemost 2001; 86:308-315.
32. Bach TL, Barsigian C, Chalupowicz DG, Busler D, Yaen CH, Grant DS,Martinez J. VE-Cadherin mediates endothelial cell capillary tube. formation in fibrin and collagen gels. Exp Cell Res 1998; 238:324-334.
33. Matsumura T, Wolff K, Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol 1997; 158:3408-3416.
34. Gleeson LM, Chakraborty C, McKinnon T, Lala PK. Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab 2001; 86:2484-2493.
35. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P, Lala PK.Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 2001; 86:3665-3674.
36. Nicola C, Timoshenko AV, Dixon SJ, Lala PK, Chakraborty C. EP1 receptor-mediated migration of the first trimester human extravillous trophoblast: the role of intracellular calcium and calpain. J Clin Endocrinol Metab 2005; 90:4736-4746.
37. Kalkunte S, Lai Z, Tewari N, Chichester C, Romero R, Padbury J, Sharma S. In vitro and in vivo evidence for lack of endovascular remodeling by third trimester trophoblasts. Placenta 2008; 29:871-878.
38. Kilburn BA, Wang J, Duniec-Dmuchowski ZM, Leach RE, Romero R,Armant DR. Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod 2000; 62:739-747.
39. Nicola C, Chirpac A, Lala PK, Chakraborty C. Roles of rho guanosine 50-triphosphatase A, rho kinases, and extracellular signal regulated kinase (1/2) in prostaglandin E2-mediated migration of first-trimester humanextravillous trophoblast. Endocrinology 2008; 149:1243-1251.
40. Nicola C, Lala PK, Chakraborty C. Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42. Biol Reprod 2008; 78:976-982.
41. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25:402-408.
42. Yao JS, Chen Y, Zhai W, Xu K, Young WL, Yang GY. Minocycline exerts multiple inhibitory effects on vascular endothelial growth factorinduced smooth muscle cell migration: the role of ERK1/2, PI3K, and matrix metalloproteinases. Circ Res 2004; 95:364-371.
43. Yu J, Bian D, Mahanivong C, Cheng RK, Zhou W, Huang S. p38 mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression. J Biol Chem 2004; 279:50446-50454.
44. van der Houven van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR,Moscat J, Caceres JF The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J Cell Biol 2000; 149:307-316.
45. Herr F, Baal N, Widmer-Teske R, McKinnon T, Zygmunt M. How to study placental vascular development? Theriogenology 2010; 73:817-827.
46. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M,Damsky CH. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99:2139-2151.
47. Aldo PB, Krikun G, Visintin I, Lockwood C, Romero R, Mor G. A novel three-dimensional in vitro system to study trophoblast-endothelium cell interactions. Am J Reprod Immunol 2007; 58:98-110.
48. Francis ME, Uriel S, Brey EM. Endothelial cell-matrix interactions in neovascularization. Tissue Eng Part B Rev 2008; 14:19-32.
49. Hu Y, Eastabrook G, Tan R, MacCalman CD, Dutz JP, von Dadelszen P. Decidual NK cell-derived conditioned medium enhances capillary tubeand network organization in an extravillous cytotrophoblast cell line.Placenta 2010; 31:213-221.
50. Fukushima K, Miyamoto S, Tsukimori K, Kobayashi H, Seki H, Takeda S, Kensuke E, Ohtani K, Shibuya M, Nakano H. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line. Biol Reprod 2005; 73:172-179.
51. Fukushima K, Murata M, Hachisuga M, Tsukimori K, Seki H, Takeda S,Asanoma K, Wake N. Hypoxia inducible factor 1 alpha regulates matrigelinduced endovascular differentiation under normoxia in a human extravillous trophoblast cell line. Placenta 2008; 29:324-331.
52. Fukushima K, Murata M, Hachisuga M, Tsukimori K, Seki H, Takeda S,Kato K, Wake N. Gene expression profiles by microarray analysis during matrigel-induced tube formation in a human extravillous trophoblast cellline: comparison with endothelial cells. Placenta 2008; 29:898-904.
53. Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal JP, Mazouni C, Feige JJ, Alfaidy N. Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 2009; 13:2224-2235.
54. Waddell JM, Evans J, Jabbour HN, Denison FC. CTGF expression is upregulated by PROK1 in early pregnancy and influences HTR-8/Svneo cell adhesion and network formation. Hum Reprod 2011; 26:67-75.
55. Tabiasco J, Rabot M, Aguerre-Girr M, El CH, Berrebi A, Parant O,Laskarin G, Juretic K, Bensussan A, Rukavina D, Le BP. Human decidual NK cells: unique phenotype and functional properties-a review. Placenta 2006; 27(Suppl A):S34-S39.
56. Cooper JC, Sharkey AM, McLaren J, Charnock-Jones DS, Smith SK.Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by immunohistochemistry. J Reprod Fertil 1995; 105:205-213.
57. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 2000; 477:258-262.
58. Duval M, Le BF, Huot J, Gratton JP. Src-mediated phosphorylation of Hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase. Mol Biol Cell 2007; 18:4659-4668.
59. Morales-Ruiz M, Fulton D, Sowa G, Languino LR, Fujio Y, Walsh K,Sessa WC. Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res 2000; 86:892-896.
60. Kumar S, Jiang MS, Adams JL, Lee JC. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem Biophys Res Commun 1999; 263:825-831.
61. Lim KH, Zhou Y, Janatpour M, McMaster M, Bass K, Chun SH, Fisher SJ. Human cytotrophoblast differentiation/invasion is abnormal in preeclampsia. Am J Pathol 1997; 151:1809-1818.
62. Zhou Y, Damsky CH, Fisher SJ. Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest 1997; 99:2152-2164.
63. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F,Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, et al. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008; 21:279-287.
64. Tjoa ML, Levine RJ, Karumanchi SA. Angiogenic factors and preeclampsia. Front Biosci 2007; 12:2395-2402.